Mar 05, 2018
Sinovac Announces Enhancement of Corporate Governance and Management of China Operating Entity
Mar 05, 2018
Sinovac Announces Re-Election of All Directors at Annual General Meeting
Feb 07, 2018
Sinovac Provides Update on Going Private Transaction
Feb 07, 2018
Sinovac Holds 2017 Annual General Meeting of Shareholders
Jan 31, 2018
An open letter from Sinobioway Consortium to all shareholders of Sinovac Biotech Ltd. ("SVA")
Dec 29, 2017
Sinovac Schedules 2017 Annual Meeting of Shareholders
Dec 22, 2017
Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization
Dec 01, 2017
Sinovac Reports Unaudited First Half of 2017 Financial Results
Dec 01, 2017
Sinovac Biotech Cures Nasdaq Filing Deficiency
Nov 30, 2017
Sinovac Biotech Announces Update on Nasdaq Matters
Nov 22, 2017
Sinovac Files 2016 Annual Report on Form 20-F and Reports Unaudited Fourth Quarter 2016 Financial Results
Nov 08, 2017
Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel
Nov 03, 2017
Sinovac Biotech Announces Receipt of Delisting Determination Letter from Nasdaq
Sep 25, 2017
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
Aug 14, 2017
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
Jul 07, 2017
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
Jun 28, 2017
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And Their Low Price, Sinobioway Consortium Raises Its Purchase Price To $8 Per Share
Jun 26, 2017
Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction